Skip to main content
. 2017 Feb;214(2):269–283. doi: 10.1084/jem.20161846

Figure 3.

Figure 3.

Schematic representation of the generation of EBV-specific T cells to treat EBV-associated disease. PBMCs are isolated from donors and stimulated using different approaches to generate EBV-specific T cells, which are then infused into patients after conditioning or immunosuppressive therapy.